Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile
Physician's Weekly
JUNE 25, 2025
from Oslo University Hospital in Norway, and colleagues examined the efficacy and safety of FMT in primary CDI in a randomized, open-label, noninferiority trial. percent of 51 patients receiving FMT versus 61.2 percent of 49 patients receiving vancomycin (difference, 5.4 Frederik Emil Juul, M.D., percentage points; 95.2
Let's personalize your content